300 related articles for article (PubMed ID: 26400282)
1. Relationship between vitamin D receptor (VDR) polymorphisms and the efficacy of recombinant human growth hormone (rhGH) treatment in children with idiopathic short stature.
Wang W; Luo XP; Cai LX; Cui ZR; Luo XY; Luo RK
Genet Mol Res; 2015 Sep; 14(3):10507-14. PubMed ID: 26400282
[TBL] [Abstract][Full Text] [Related]
2. Association of polymorphisms in the vitamin D receptor promoter with idiopathic short stature.
Choi SK; Park MS; Song JK; Yoon KS; Yoon KL; Shim KS
J Korean Med Sci; 2013 Sep; 28(9):1329-33. PubMed ID: 24015038
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
4. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
[TBL] [Abstract][Full Text] [Related]
5. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
6. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
[TBL] [Abstract][Full Text] [Related]
7. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
[TBL] [Abstract][Full Text] [Related]
8. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
Costalonga EF; Antonini SR; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
[TBL] [Abstract][Full Text] [Related]
10. Correlation between exon 3 polymorphism of growth hormone receptor gene and the responses to rhGH therapy.
Wei Y; Zheng R; Zhou Y; Wang J; Bao P
Int J Clin Exp Pathol; 2015; 8(6):7371-7. PubMed ID: 26261638
[TBL] [Abstract][Full Text] [Related]
11. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
Liu HJ; Wang LH; Chen L
Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
[TBL] [Abstract][Full Text] [Related]
13. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene.
Arai H; Miyamoto KI; Yoshida M; Yamamoto H; Taketani Y; Morita K; Kubota M; Yoshida S; Ikeda M; Watabe F; Kanemasa Y; Takeda E
J Bone Miner Res; 2001 Jul; 16(7):1256-64. PubMed ID: 11450701
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
Costalonga EF; Antonini SR; Guerra G; Coletta RR; Franca MM; Braz AF; Mendonca BB; Arnhold IJ; Jorge AA
Pharmacogenomics J; 2012 Oct; 12(5):439-45. PubMed ID: 21468024
[TBL] [Abstract][Full Text] [Related]
15. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children.
Hellgren G; Glad CA; Jonsson B; Johannsson G; Albertsson-Wikland K
Growth Horm IGF Res; 2015 Jun; 25(3):127-35. PubMed ID: 25742716
[TBL] [Abstract][Full Text] [Related]
16. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA
Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512
[TBL] [Abstract][Full Text] [Related]
17. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
Ross JL; Lee PA; Gut R; Germak J
Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
[TBL] [Abstract][Full Text] [Related]
18. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in the leptin receptor gene at position 223 is associated with growth hormone replacement therapy responsiveness in idiopathic short stature and growth hormone deficiency patients.
Su PH; Yang SF; Yu JS; Chen SJ; Chen JY
Eur J Med Genet; 2012 Dec; 55(12):682-7. PubMed ID: 23009903
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in the locus control region and promoter of GH1 are related to serum IGF-I levels and height in patients with isolated growth hormone deficiency and healthy controls.
de Graaff LC; Argente J; van Meurs JB; Uitterlinden AG; Hokken-Koelega AC
Horm Res Paediatr; 2010; 73(1):25-34. PubMed ID: 20190537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
